Skip to main content
TNXP filings

Corporate insider profile

Seth Lederman Filing Activity

Latest reported as Chief Executive Officer of Tonix Pharmaceuticals Holding Corp. (TNXP).

Purchase filings
1
Reported companies
1
Net open-market value
$58,950
Latest transaction
Jun 9, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 9, 2026Tonix Pharmaceuticals Holding Corp. (TNXP)Chief Executive OfficerOpen Market Purchase5,000$11.79$58,950